Literature DB >> 1407982

Effect of brief exposure to mitomycin C on viability and proliferation of cultured human Tenon's capsule fibroblasts.

H D Jampel1.   

Abstract

PURPOSE: The purpose of this study is to determine why a single intraoperative dose of mitomycin C (MMC) appears to promote the success of glaucoma filtration surgery.
METHODS: Human Tenon's capsule fibroblasts were exposed to MMC and 5-fluorouracil (5-FU) in vitro at the concentrations and durations of exposure used clinically. Cell proliferation was assessed by quantification of 3H-thymidine uptake. Cell viability was studied using a sulfarhodamine B cell protein stain and by trypan blue exclusion.
RESULTS: Neither MMC (0.4 mg/ml) nor 5-FU (40 mg/ml) were cytocidal. Both 1- and 5-minute exposures to MMC were antiproliferative. A 1-minute exposure to 0.4 mg/ml inhibited 3H-thymidine uptake by 77%. For the 5-minute exposure, 3H-thymidine uptake was inhibited by 50% at 0.06 mg/ml and by 90% at 0.4 mg/ml. For 5-FU, 3H-thymidine uptake was inhibited by 50% at 10 mg/ml and by 64% at 40 mg/ml.
CONCLUSIONS: Mitomycin C probably does not improve the success of filtration surgery by killing fibroblasts. The ability of a brief exposure to MMC to improve filtration surgery may be due to an almost complete inhibition of proliferation. Alternatively, it may be due to sustained tissue binding, effects on other components of wound healing, such as cell migration and extracellular matrix production, or effects on the vasculature. A 1-minute exposure may be as effective as a 5-minute exposure.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1407982     DOI: 10.1016/s0161-6420(92)31781-6

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  48 in total

1.  Efficacy and safety of mitomycin C as an agent to treat corneal scarring in horses using an in vitro model.

Authors:  Dylan G Buss; Ajay Sharma; Elizabeth A Giuliano; Rajiv R Mohan
Journal:  Vet Ophthalmol       Date:  2010-07       Impact factor: 1.644

2.  Collagen type I and III synthesis by Tenon's capsule fibroblasts in culture: individual patient characteristics and response to mitomycin C, 5-fluorouracil, and ascorbic acid.

Authors:  R L Gross
Journal:  Trans Am Ophthalmol Soc       Date:  1999

3.  Trabeculectomy augmented with mitomycin C application under the scleral flap.

Authors:  S Beatty; T Potamitis; S Kheterpal; E C O'Neill
Journal:  Br J Ophthalmol       Date:  1998-04       Impact factor: 4.638

4.  Immunolocalization of prolyl 4-hydroxylase in fibroblasts cultured from Tenon's capsule of humans.

Authors:  S Saika; A Ooshima; O Yamanaka; O Tonoe; Y Okada; Y Ohnishi; M Kimura
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-04       Impact factor: 3.117

5.  Effect of fibrostatin C, an inhibitor of prolyl 4-hydroxylase, on collagen secretion by human Tenon's capsule fibroblasts in vitro.

Authors:  S Saika; A Ooshima; O Yamanaka; Y Okada; S Tanaka; Y Ohnishi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-08       Impact factor: 3.117

6.  Topical mitomycin C chemotherapy for conjunctival melanoma and PAM with atypia.

Authors:  P T Finger; G Czechonska; S Liarikos
Journal:  Br J Ophthalmol       Date:  1998-05       Impact factor: 4.638

7.  A sequential, multiple-treatment, targeted approach to reduce wound healing and failure of glaucoma filtration surgery in a rabbit model (an American Ophthalmological Society thesis).

Authors:  Mark Brian Sherwood
Journal:  Trans Am Ophthalmol Soc       Date:  2006

8.  Does titration of mitomycin C as an adjunct to trabeculectomy significantly influence the intraocular pressure outcome?

Authors:  Susan J Lee; Augusto Paranhos; M Bruce Shields
Journal:  Clin Ophthalmol       Date:  2009-06-02

9.  Growth inhibition of human Tenon's capsule fibroblasts and rabbit dermal fibroblasts with non-carcinogenic N-alkylated anthracyclines.

Authors:  U H Steinhorst; E P Chen; S F Freedman; R Machemer; D L Hatchell
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-06       Impact factor: 3.117

10.  Transconjunctival penetration of mitomycin C.

Authors:  T Velpandian; Ramanjit Sihota; Ankur Sinha; Viney Gupta
Journal:  Indian J Ophthalmol       Date:  2008 May-Jun       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.